Hologen, which uses AI to optimize late-stage clinical trials, has ambitious financial goalsHologen, a secretive AI startup co-founded by former Google CEO Eric Schmidt, is seeking to raise $150 million in a Series A fundraising round, STAT has learned. Hologen describes itself as a “frontier medical AI company, a drug development & diagnostics company, and […]
